Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber - a podcast by Research To Practice

Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations.
COVID-19-Related Resources in Breast CancerDietz JR et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 2020;[Online ahead of print]. Abstract (https://link.springer.com/article/10.1007/s10549-020-05644-z)Braunstein LZ et al. Breast radiotherapy under COVID-19 pandemic resource constraints —Approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States. Adv Radiat Oncol 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32292842)Coles CE et al. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol (R Coll Radiol) 2020;32(5):279-81. https://www.clinicaloncologyonline.net/article/S0936-6555(20)30122-9/pdf (https://www.clinicaloncologyonline.net/article/S0936-6555(20)30122-9/pdf)
ESMO. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/breast-cancer-in-the-covid-19-era (https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/breast-cancer-in-the-covid-19-era)

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice